DK645189A - Sulfonsyresubstituerede, aromatiske steroider, farmaceutiske midler indeholdende disse samt deres anvendelse - Google Patents

Sulfonsyresubstituerede, aromatiske steroider, farmaceutiske midler indeholdende disse samt deres anvendelse Download PDF

Info

Publication number
DK645189A
DK645189A DK645189A DK645189A DK645189A DK 645189 A DK645189 A DK 645189A DK 645189 A DK645189 A DK 645189A DK 645189 A DK645189 A DK 645189A DK 645189 A DK645189 A DK 645189A
Authority
DK
Denmark
Prior art keywords
sulphonic acid
pharmaceutical agents
agents containing
acid substituted
aromatic steroids
Prior art date
Application number
DK645189A
Other languages
Danish (da)
English (en)
Other versions
DK645189D0 (da
Inventor
Dennis Alan Holt
Mark Alan Levy
Brian Walter Metcalf
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of DK645189D0 publication Critical patent/DK645189D0/da
Publication of DK645189A publication Critical patent/DK645189A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK645189A 1988-12-23 1989-12-19 Sulfonsyresubstituerede, aromatiske steroider, farmaceutiske midler indeholdende disse samt deres anvendelse DK645189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/290,020 US4970205A (en) 1988-12-23 1988-12-23 Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase

Publications (2)

Publication Number Publication Date
DK645189D0 DK645189D0 (da) 1989-12-19
DK645189A true DK645189A (da) 1990-06-24

Family

ID=23114202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645189A DK645189A (da) 1988-12-23 1989-12-19 Sulfonsyresubstituerede, aromatiske steroider, farmaceutiske midler indeholdende disse samt deres anvendelse

Country Status (14)

Country Link
US (1) US4970205A (de)
EP (1) EP0375347B1 (de)
JP (1) JPH02225494A (de)
CN (1) CN1051181A (de)
AT (1) ATE115960T1 (de)
AU (2) AU627528B2 (de)
CA (1) CA2005215A1 (de)
DE (1) DE68920128T2 (de)
DK (1) DK645189A (de)
ES (1) ES2066003T3 (de)
GR (1) GR3015476T3 (de)
IE (1) IE894108L (de)
PT (1) PT92719A (de)
ZA (1) ZA899669B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5138063A (en) * 1984-02-27 1992-08-11 Merck & Co., Inc. 17β-methoxycarbonyl-4-aza-androsten-1-en-3-ones
US5098908A (en) * 1990-06-20 1992-03-24 Merck & Co., Inc. 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors
US5151430A (en) * 1990-06-20 1992-09-29 Merck & Co., Inc. Specific 17β-thiobenzoyl-4-aza-5α-androst-1-en-3-ones as antiandrogen agents
US5162332A (en) * 1990-06-20 1992-11-10 Merck & Co., Inc. Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors
US5061802A (en) * 1990-06-20 1991-10-29 Merck & Co. Inc. 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
NZ241979A (en) * 1991-03-20 1996-01-26 Merck & Co Inc Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
IL104303A0 (en) * 1992-01-06 1993-05-13 Smithkline Beecham Corp Process
SK137994A3 (en) * 1992-05-20 1995-04-12 Merck & Co Inc 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
WO1993023040A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. 17-ethers and thioethers of 4-aza-steroids
WO1993023048A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. 4-azasteroid 5-alpha-reductase inhibitors
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
ATE198601T1 (de) * 1992-05-20 2001-01-15 Merck & Co Inc Ester derivate von 4-aza-steroiden
CA2135057A1 (en) * 1992-05-20 1993-11-25 Bruce E. Witzel 17-amino substituted 4-azasteroid 5a-reductase inhibitors
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5324734A (en) * 1992-09-15 1994-06-28 Merck & Co., Inc. Oxidization metabolites of 5-α-23-methyl-4-aza-21-nor-chol-1-ene-3, 20-dione
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids
WO1994021614A1 (en) * 1993-03-24 1994-09-29 Merck & Co., Inc. SUBSTITUTED 3-PHENANTHRIDINONE DERIVATIVES AS 5α-REDUCTASE INHIBITORS
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.
CA2165077A1 (en) * 1993-06-28 1995-01-05 Philippe L. Durette 4-aza-pregnane 5.alpha.-reductase isozyme 1 inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5637310A (en) * 1993-12-20 1997-06-10 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555579A (en) * 1950-05-24 1951-06-05 Ayerst Mckenna & Harrison P-aminobenzoyl-diethyl aminoethanol salts of steroids 3-monosulphates
DE1107664B (de) * 1959-11-05 1961-05-31 Schering Ag Verfahren zur Herstellung neuer in 3-Stellung substituierter OEstratriene
FR1521896A (fr) * 1966-05-04 1968-04-19 Ohio State University Represen Procédé de transformation de thioncarbamates en thiolcarbamates
GB1219869A (en) * 1968-07-24 1971-01-20 Farmaceutici Italia Stabilized estrogen sulphate salts
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4179453A (en) * 1978-04-13 1979-12-18 Merck & Co., Inc. Process for preparing 17β-carboxy-5-androsten-3-ones
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider
JPS5953417A (ja) * 1982-09-21 1984-03-28 Shiseido Co Ltd 皮膚外用剤
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
JPS60142941A (ja) * 1983-12-28 1985-07-29 Ono Pharmaceut Co Ltd ケトン化合物
JPS60146855A (ja) * 1984-01-11 1985-08-02 Ono Pharmaceut Co Ltd アニリン誘導体
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
EP0375347B1 (de) 1994-12-21
GR3015476T3 (en) 1995-06-30
AU627528B2 (en) 1992-08-27
DK645189D0 (da) 1989-12-19
ATE115960T1 (de) 1995-01-15
AU2960292A (en) 1993-01-21
PT92719A (pt) 1990-06-29
DE68920128D1 (de) 1995-02-02
DE68920128T2 (de) 1995-05-11
EP0375347A1 (de) 1990-06-27
AU4700589A (en) 1990-06-28
US4970205A (en) 1990-11-13
CN1051181A (zh) 1991-05-08
AU655691B2 (en) 1995-01-05
ES2066003T3 (es) 1995-03-01
ZA899669B (en) 1990-11-28
IE894108L (en) 1990-06-23
CA2005215A1 (en) 1990-06-23
JPH02225494A (ja) 1990-09-07

Similar Documents

Publication Publication Date Title
DK645189D0 (da) Sulfonsyresubstituerede, aromatiske steroider, farmaceutiske midler indeholdende disse samt deres anvendelse
ATE114666T1 (de) Phosphonsäure-derivate von aromatischen steroiden als 5-alpha-reduktase-inhibitoren.
DE68921174D1 (de) Phosphinsäure-Derivate von aromatischen Steroiden als 5-alpha Reduktase-Inhibitoren.
DK645389A (da) Phosphinsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse
DK37388D0 (da) Steroid-5-alfa-reduktaseinhibitorer
NO881940L (no) 4-aminokinolin-derivater og deres anvendelse som legemidler.
PT773022E (pt) Preparacao farmaceutica para o tratamento de rinites agudas contendo simpaticomimeticos e pantotenol e/ou acido pantotenico
DK84088D0 (da) Naphthalenderivater med anvendelse som antiallergiske og antiinflammatoriske midler
ATE110736T1 (de) Phosphonsäure-derivate von steroiden als hemmstoffe der 5-alpha-reduktase.
PT89788A (pt) Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem
DK163185C (da) 1h-imidazol-1-ethanol og estere deraf og deres farmaceutisk acceptable syreadditionssalte til anvendelse som talgsyntesehaemmende midler samt farmaceutiske praeparater indeholdende saadanne forbindelser
NO308607B1 (no) Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
DK599885A (da) Trienamidforbindelser og farmaceutisk acceptable salte heraf med antiinflammatorisk og analgetisk virkning samt farmaceutisk komposition indeholdende disse
IT8621828A1 (it) Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
DE68924416D1 (de) Carboximidamid-Derivate.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment